Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Lowered by Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

A number of other equities research analysts also recently weighed in on the company. Bank of America raised their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Oppenheimer increased their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Zacks Research cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Finally, Weiss Ratings downgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Guardian Pharmacy Services presently has an average rating of “Moderate Buy” and an average price target of $42.83.

Guardian Pharmacy Services Trading Down 0.3%

Shares of NYSE GRDN opened at $39.43 on Friday. The stock has a market capitalization of $1.96 billion, a PE ratio of 47.50, a price-to-earnings-growth ratio of 2.59 and a beta of 0.11. The stock’s fifty day simple moving average is $40.72 and its two-hundred day simple moving average is $36.74. Guardian Pharmacy Services has a 12-month low of $19.30 and a 12-month high of $44.00.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. The business had revenue of $336.60 million for the quarter, compared to the consensus estimate of $329.89 million. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The business’s revenue was up 2.2% compared to the same quarter last year. During the same period last year, the business posted $0.22 EPS. On average, equities analysts predict that Guardian Pharmacy Services will post 1.18 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. increased its position in Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Guardian Pharmacy Services in the second quarter valued at about $43,000. State of Wyoming acquired a new stake in Guardian Pharmacy Services in the second quarter worth about $58,000. Strs Ohio acquired a new stake in Guardian Pharmacy Services in the fourth quarter worth about $75,000. Finally, Clearstead Advisors LLC grew its stake in shares of Guardian Pharmacy Services by 196.3% during the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after acquiring an additional 1,741 shares during the last quarter.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.